Jasper Therapeutics, Inc.·4

Feb 18, 5:29 PM ET

Tucker Edwin Jonathan 4

4 · Jasper Therapeutics, Inc. · Filed Feb 18, 2025

Insider Transaction Report

Form 4
Period: 2025-02-13
Tucker Edwin Jonathan
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2025-02-13+50,00050,000 total
    Exercise: $6.20Exp: 2035-02-13Voting Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]1/4th of the shares subject to the option shall vest on February 13, 2026, and 1/48th of the original number of shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Documents

1 file
  • 4
    ownership.xmlPrimary